Safety of Using Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Chronic Kidney Disease

The purpose of this review is to examine the possibilities and prospects for the use of direct oral anticoagulants for the prevention of thromboembolic complications in patients with atrial fibrillation and chronic kidney disease. Chronic kidney disease is an independent risk factor for cardiovascul...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Principais autores: V. I. Petrov, O. V. Shatalova, A. S. Gerasimenko, V. S. Gorbatenko
Formato: Artigo
Idioma:Inglês
Publicado em: Stolichnaya Izdatelskaya Kompaniya 2019-09-01
coleção:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Assuntos:
atrial fibrillation
chronic kidney disease
direct oral anticoagulants
warfarin
Acesso em linha:https://www.rpcardio.com/jour/article/view/2006
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados